Navigation Links
FreshFx Recognized for use in the Scalder as a Solution to the 'Yield/Pathogen Reduction Dilemma'
Date:11/6/2007

Article in Watt Poultry USA states that acidic treatments benefit poultry

processing plants.

SHREVEPORT, La., Nov. 6 /PRNewswire/ -- FreshFx Antimicrobial Solution, which is used to reduce pathogens during poultry processing, was identified in an October 2007 Watt Poultry USA article as helping to solve the "yield/pathogen reduction dilemma."

Citing recent studies in large-scale processing plants, University of Georgia Associate Professor of Poultry Science Scott Russell, Ph.D., stated that adding an acidic disinfectant chemical (such as FreshFx) during scalding "benefits the system, allowing scalder temperatures to be lowered without the concern that Salmonella will begin to grow. And, acids greatly improve picking."

FreshFx is USDA-approved for use anywhere along the processing line: pre-evisceration in the scalder, over picking rails and in the New York rinse; throughout evisceration and for on-line reprocessing (OLR) as rinses or dips; and for pH control in the chillers, as well as post-chill. Since its approval as a processing aid in January 2003, FreshFx has been used to disinfect nearly 2 billion birds.

"FreshFx can maintain antimicrobial activity even in the presence of the accumulated organic load found in scalder water and other immersion systems," said John Dankert, Ph.D., CEO of SteriFx Inc., which manufactures FreshFx. "This contrasts sharply with alternatives that would 'gas-off' at high temperatures or be inhibited by the organic load, reducing effectiveness."

The ability to use lower temperatures for scalding reduces energy costs and decreases the amount of fats and oils that are released, which enhances antimicrobial effectiveness. Also, when less fats and oils are released, an increase in yield not related to moisture might be obtained.

Of course, lower temperatures can also create an environment where Salmonella and other pathogens can thrive, and also lead to less efficient p
'/>"/>

SOURCE SteriFx Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Tourtellotte Solutions Blazes Trail with New Release of Clinical Trial Supply Chain Simulator
2. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
3. Data from Three Clinical Trials for Perforomist(TM) Inhalation Solution to be Presented at CHEST 2007 on October 24, 2007
4. Studies Show Body Mass Index Has No Effect on Resolution and Healing of GERD Symptoms
5. Facet Solutions Enjoys Continued Clinical Success With the Anatomic Facet Replacement System (AFRS(TM))
6. Facet Solutions AFRS(TM) Demonstrates Biomechanical Advantages Over Dynamic Stabilization in Independent Testing
7. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
8. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
9. DOV 21,947 Demonstrates Significant Body Weight and BMI Reductions in Drug- Compliant Subjects in Phase Ib Clinical Study
10. Rotigotine Transdermal System Shows Significant Symptom Reduction and Tolerability in Patients with Restless Legs Syndrome
11. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... /PRNewswire-iReach/ -- DeepResearchReports.com adds "2014 Deep Research Report ... "2014 Deep Research Report on Global and China ... database. Photo - http://photos.prnewswire.com/prnh/20140731/132164 ... on Global and China Potassium Nitrate  Industry" is ... China and Global Potassium Nitrate ...
(Date:7/31/2014)... , July 31, 2014  According to data released ... the 2015 average monthly Medicare Part D premium is ... lower than was originally projected, the Pharmaceutical Care Management ... program continues to be a bright spot in American ... in each region and using cutting edge, cost-saving tools ...
(Date:7/31/2014)... Surgical Company (NASDAQ: STAA ) a leading ... systems for the eye today reported revenue for the ... a 10% increase over $18.2 million reported for the ... revenues grew 11% during the second quarter of 2014 ... of foreign currency exchange reduced sales by $0.1 million ...
Breaking Medicine Technology:Potassium Nitrate Market & Tricalcium Phosphate Industry Analysis for Global & China Regions 2Potassium Nitrate Market & Tricalcium Phosphate Industry Analysis for Global & China Regions 3Potassium Nitrate Market & Tricalcium Phosphate Industry Analysis for Global & China Regions 4Potassium Nitrate Market & Tricalcium Phosphate Industry Analysis for Global & China Regions 5STAAR Surgical Reports 10% Second Quarter Revenue Growth 2STAAR Surgical Reports 10% Second Quarter Revenue Growth 3STAAR Surgical Reports 10% Second Quarter Revenue Growth 4STAAR Surgical Reports 10% Second Quarter Revenue Growth 5STAAR Surgical Reports 10% Second Quarter Revenue Growth 6STAAR Surgical Reports 10% Second Quarter Revenue Growth 7STAAR Surgical Reports 10% Second Quarter Revenue Growth 8STAAR Surgical Reports 10% Second Quarter Revenue Growth 9STAAR Surgical Reports 10% Second Quarter Revenue Growth 10STAAR Surgical Reports 10% Second Quarter Revenue Growth 11STAAR Surgical Reports 10% Second Quarter Revenue Growth 12STAAR Surgical Reports 10% Second Quarter Revenue Growth 13STAAR Surgical Reports 10% Second Quarter Revenue Growth 14STAAR Surgical Reports 10% Second Quarter Revenue Growth 15STAAR Surgical Reports 10% Second Quarter Revenue Growth 16STAAR Surgical Reports 10% Second Quarter Revenue Growth 17STAAR Surgical Reports 10% Second Quarter Revenue Growth 18STAAR Surgical Reports 10% Second Quarter Revenue Growth 19STAAR Surgical Reports 10% Second Quarter Revenue Growth 20STAAR Surgical Reports 10% Second Quarter Revenue Growth 21STAAR Surgical Reports 10% Second Quarter Revenue Growth 22STAAR Surgical Reports 10% Second Quarter Revenue Growth 23STAAR Surgical Reports 10% Second Quarter Revenue Growth 24STAAR Surgical Reports 10% Second Quarter Revenue Growth 25STAAR Surgical Reports 10% Second Quarter Revenue Growth 26STAAR Surgical Reports 10% Second Quarter Revenue Growth 27STAAR Surgical Reports 10% Second Quarter Revenue Growth 28STAAR Surgical Reports 10% Second Quarter Revenue Growth 29STAAR Surgical Reports 10% Second Quarter Revenue Growth 30STAAR Surgical Reports 10% Second Quarter Revenue Growth 31
... (NYSE-Amex: NBS ) today announced that it intends to ... an underwritten public offering. All of the shares and warrants in ... to market conditions, and there can be no assurance as to ... the actual size or terms of the offering. The shares will ...
... Ohio, July 18, 2011 BioTech Medical, Inc. announces the ... Dental Chair Pad and Head Cushion to its ... "There isn,t a day that goes by that our ... Tippey, Director of Medical Operations for BioTech Medical, Inc.  "We ...
Cached Medicine Technology:NeoStem Announces Proposed Public Offering of Common Stock 2NeoStem Announces Proposed Public Offering of Common Stock 3
(Date:8/1/2014)... Everett, WA (PRWEB) August 01, 2014 ... a problem throughout your entire home.“ In a newly ... Space or Attic Insulation Needs To Be Replaced ,” ... has deteriorated, become damp, or been infested by critters. ... space cleaning quote from Clean Crawls - http://www.cleancrawl.com/contact ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 The Multiple System ... to serving patients, caregivers and families affected by the neurological ... Kramer Sutton of La Coste, TX to its Board of ... of 39 years, Eric Sutton. He was diagnosed officially with ... at home with his family. Like many others with this ...
(Date:8/1/2014)... 01, 2014 Narrow networks that ... and employers effective options to trim pharmacy costs ... that they can enhance formulary compliance and achieve ... report that nearly all PBMs now include a ... proposals. The Aug. 12 webinar from Atlantic ...
(Date:8/1/2014)... 01, 2014 Millions of women suffer ... legs and in some cases the arms, causing an ... about 17 million women in the U.S. alone are ... with the pain, embarrassment and discomfort caused by lipedema, ... physicians are unaware that this is a disease,” says Dr. ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 Get the ... partnership with PitchBook presents the 3Q 2014 Private Equity ... private equity investment, exits and fundraising activity in the ... to help plan for private equity endeavors for the ... form to download it now. , About Merrill DataSite ...
Breaking Medicine News(10 mins):Health News:5 Signs That Insulation Should Be Replaced Detailed in a Newly Released Article By Clean Crawls 2Health News:Sharon Kramer Sutton, 30 Year Veteran of Rare Disease Advocacy, Appointed to Multiple System Atrophy Coalition Board of Directors 2Health News:Sharon Kramer Sutton, 30 Year Veteran of Rare Disease Advocacy, Appointed to Multiple System Atrophy Coalition Board of Directors 3Health News:Atlantic Information Services Webinar to Offer Health Plan, Employer Strategies for Implementing Narrow Pharma Networks 2Health News:Lipedema Centers Works With Insurers To Gain Coverage For Lipedema Treatment 2Health News:Register to Download Merrill DataSite's Report: PitchBook 3Q 2014 Private Equity Breakdown Report 2
... Nov. 21 Inverness Medical,Innovations, Inc. (Amex: IMA ... offering on Tuesday. The Company sold a total,of 13,634,302 ... of $61.49,per share. The total number of shares sold ... upon their exercise of their,over-allotment option in full. Certain ...
... The precise tailoring of tumor target treatment for patients ... to only administer treatments that have a high probability ... on imaging technologies, which are used to detect tumors ... guide therapy or surgery. , Vascular endothelial growth ...
... arterial vascular disease is widespread and often deadly among ... and treat it, according to a new report by ... Medical Center and Weill Cornell Medical College campuses of ... the fact that for years, cardiovascular research has focused ...
... Portable M5 Diagnostic Imaging Systems, SHENZHEN, China, ... MR ), a leading developer, manufacturer,and marketer ... growing,international presence, today announced that it will attend ... in Chicago,Illinois at the McCormick Place from November ...
... 21 Genomic Health,Inc. (Nasdaq: GHDX ) ... and Chief Executive Officer, will present at the ... on November 28, 2007 at 1:00,p.m. Eastern Time., ... webcast of the,presentation, visit the Investor Relations section ...
... Eclipsys Corporation(R),(Nasdaq: ECLP ), The Outcomes ... Merrill Lynch Health Services Investor Conference,taking place next ... http://www.newscom.com/cgi-bin/prnh/20050209/FLW006LOGO ), Eclipsys executives will present ... a.m. Eastern time. Interested parties are invited to,listen ...
Cached Medicine News:Health News:Inverness Medical Innovations Announces Closing of Public Offering 2Health News:Arterial vascular disease underdiagnosed, undertreated in older US women 2Health News:Arterial vascular disease underdiagnosed, undertreated in older US women 3Health News:Arterial vascular disease underdiagnosed, undertreated in older US women 4Health News:Mindray to Attend 2007 RSNA Conference in Chicago 2Health News:Mindray to Attend 2007 RSNA Conference in Chicago 3Health News:Genomic Health to Present at 19th Annual Piper Jaffray Health Care Conference 2Health News:Eclipsys to Present at the Merrill Lynch Health Services Investor Conference 2Health News:Eclipsys to Present at the Merrill Lynch Health Services Investor Conference 3
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Low-profile, hand-held instrument....
Low-profile, hand-held instrument....
Medicine Products: